The Importance of Molecular Testing in CRC
August 22nd 2018Scott Kopetz, MD, PhD, FACP, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the importance of molecular testing in colorectal cancer.
Watch
Selecting Patients With Renal Cell Carcinoma for Adjuvant Sunitinib Therapy
August 21st 2018Daniel J. George, MD, professor of medicine and surgery at Duke Cancer Institute, discusses his rationale for choosing patients with renal cell carcinoma that should receive adjuvant sunitinib therapy.
Watch
Understanding the Unique Adverse Events Associated With Immunotherapy Agents
August 21st 2018Benjamin P. Levy, MD, clinical director of Medical Oncology at John Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, discusses the unique adverse events with immunotherapy agents and how physicians can work together to overcome these challenges.
Watch
Lead-In Treatment to Reduce Tumor Lysis Syndrome Risk in CLL
August 21st 2018Kerry Rogers, MD, assistant professor at The Ohio State University Comprehensive Cancer Center, discusses a short-term treatment strategy for reducing tumor burden and the risk for tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Watch